December 1, 2020

AMR Action Fund ($1b for P2-3) seeks Scientific Advisory Board

Dear All, I’ve previously written about the AMR Action Fund (9 Jul 2020 newsletter), a $1b fund created by 20+ global pharma with the intertwined goals of (i) bringing 2-4 new antibacterial antibiotics through Phase 2-3 and approval by 2030 and (ii) creating market conditions that enable sustainable investment in antibiotics. While we know that the

Read More »
Scroll to Top